Post Authorisation Safety Study of Triaxis as a 5th Dose in 4-6 Year Old Spanish Children

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

556 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-03-31

Study Completion Date

2012-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Primary objective: This is a descriptive study and the primary objective is to determine the incidence of injection site and systemic adverse events after Triaxis administration as a 5th dose of tetanus, diphtheria and acellular pertussis vaccine in 4-6 year old children

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Immunogenicity and Reactogenicity Study of BoostrixTM (dTpa) and Boostrix-IPV (dTpa-IPV)

NCT01294605

Acellular Pertussis Tetanus Diphtheria

COMPLETED PHASE4

An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster

NCT00870350

Tetanus Diphtheria Pertussis

UNKNOWN PHASE4

Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age

NCT00467519

Tetanus Diphtheria Pertussis

COMPLETED PHASE3

Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects

NCT02587520

Tetanus Diphtheria Pertussis +1 more

COMPLETED PHASE1/PHASE2

Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine

NCT00304265

Pertussis Diphtheria Tetanus +1 more

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diphtheria, Tetanus and Pertussis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 4 to 6 years on the day of enrolment.
* Have received, on the day of enrolment, immunisation with Triaxis as a 5th dose for diphtheria, tetanus, pertussis vaccination in routine practice in accordance with the Spanish version of the EU SmPC and the Spanish immunisation recommendations.
* Have received a complete course of immunisation with diphtheria, tetanus and pertussis (4 doses).
* Participant and participant´s parent/legal representative are able to comply with all study procedures.
* Written informed consent obtained from at least one parent/legal representative of the participant before the participant is enrolled in the study

Exclusion Criteria

* Have been previously vaccinated with a 5th dose of tetanus, diphtheria and pertussis.
* Presence of a contra-indication or cautions to vaccination in accordance with the Spanish version of the EU SmPC:

1. Hypersensitivity to vaccines of diphtheria, tetanus or pertussis, any component of the vaccine and any residual component of the manufacturing process such as formaldehyde and glutaraldehyde that may be present in trace amounts.
2. Encephalopathy of unknown origin within 7 days after a prior immunisation with a vaccine against pertussis.
3. Progressive neurological disorder, uncontrolled epilepsy, progressive encephalopathy if no treatment has been established and the condition is not stable.
4. Acute severe febrile illness or acute infection.

Minimum Eligible Age

4 Years

Maximum Eligible Age

6 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes